Home >  News >  January, 2017

Trial to Begin for Pharmacist Linked to Deadly Fungal Meningitis Outbreak

Opening arguments set for Monday in trial of Barry Cadden, the owner of the New England Compounding Center.

Published: January 5, 2017

COMPOUNDING DISASTER New England Compounding Center President Barry Cadden.

Next week a federal jury in Boston, Mass., will begin hearing arguments on the largest and deadliest drug contamination disaster in the country's history, but federal prosecutors will be barred from telling the jurors just how deadly it was.

Scheduled for opening arguments Monday is the criminal trial of Barry Cadden, a former pharmacist and owner of the now-defunct New England Compounding Center in Framingham, Mass, who is facing charges of racketeering, 25 counts of second-degree murder and mail and wire fraud charges.

According to a filing by a federal agent in a related case, 76 patients died from fungus-riddled steroids NECC shipped to surgery centers, hospitals and pain clinics.

Joseph Ridgley, a special agent for the U.S. Food and Drug Administration, wrote in the affidavit that the criminal investigation turned up 12 more deaths than had been reported by the U.S. Centers for Disease Control and Prevention. And, the total number of patients sickened was 778, up from the 751 in the official CDC count.

But neither the FDA count nor the lower CDC count can be mentioned in Mr. Cadden's trial under a ruling issued this week by U.S. District Judge Richard G. Stearns. Under his order, prosecutors can refer to the outbreak in general terms and cite "multiple deaths," but not the case counts.

compounding disaster cover

Outpatient Surgery will bring you continuing coverage of the New England Compounding Center trial.

Nor can prosecutors provide details of any deaths beyond the 25 specifically cited in the 131-count indictment.

One possible prosecution witness is Robert Ronzio, who worked for NECC's sales affiliate, Medical Sales Management. Mr. Ronzio has entered a guilty plea to a single count of conspiracy to defraud the FDA. Under his plea agreement, Mr. Ronzio agreed to assist prosecutors.

In a series of pre-trial motions Mr. Cadden's lawyer, Bruce Singal, has sought to limit or even eliminate testimony from some of the prosecution witnesses. Judge Stearns has granted some, but not all of those requests.

The Cadden trial will be followed by the trial of NECC's supervising pharmacist Glenn Chin, who also faces second-degree murder charges. Pretrial filings indicate that Mr. Cadden intends to charge that it was "Chin and Chin alone" who was responsible for the deaths.

The remaining NECC defendants are scheduled for trial in April.

Walter F. Roche, Jr.

Mr. Roche is a former reporter for the Baltimore Sun and Nashville Tennessean who covers the meningitis case on his blog.


Also in the News...

Police: Director of Surgery Center Tried to Traffic 28g of Fentanyl
A Look at Health Care's Reimbursement Future at ORX
At ORX, Why Open Disclosure Bests Deny and Defend
Study Finds Patients Fare Better When the Surgeon is Female
At ORX, The Case for Giving Disruptive Docs a Second Chance
ORX Attendees Learn Why Patients Come Second
Study: "Frailty" a Better Predictor of Complications Than Age in Low-Risk Surgeries

New to Outpatient Surgery Magazine?
Sign-up to continue reading this article.
Register Now
Have an account? Please log in:
Email Address:
  Remember my login on this computer

advertiser banner

Other Articles That May Interest You

Spine Practice Pays $1.9M to Resolve Improper Billing Practices

Hospital in Hot Water After Staff Snap Pics of Patient's Penis

Judge Blocks Further Testimony by Victims of the 2012 Fungal Meningitis Outbreak

"The emotional impact on the jurors has been visible to the court," judge writes in his ruling.